ABNCoV2 Vaccine in Adult Subjects Previously Vaccinated for SARS-CoV-2

Clinical trial NCT05329220 · COMPLETED

Trial details

NCT number: NCT05329220
Sponsor: Bavarian Nordic
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

COVID-19 Disease

Start date: 2022-08-30
Primary completion: 2023-03-15
Enrollment: 4205

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.